FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093632 [Registered on: 25/08/2025] Trial Registered Prospectively
Last Modified On: 25/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Prospective Cross Sectional Study Of Role Of MRI in Evaluation Of Solid Supratentorial Neoplasms In Adult And Pediatric Population. 
Scientific Title of Study   Role Of MRI in Evaluation Of Solid Supratentorial Neoplasms In Adult And Pediatric Population. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Paritosh Bhangale 
Designation  Junior Resident 
Affiliation  Datta Meghe Institute Of Higher Education And Research 
Address  Department Of radiodiagnosis, Jawaharlal Nehru Medical College, Sawangi, Wardha, Maharashtra - 442001.

Wardha
MAHARASHTRA
442001
India 
Phone  9967647919  
Fax    
Email  paritosh.bhangale@gmail.com  
 
Details of Contact Person
Scientific Query  
Name  Dr Shivali Kashikar 
Designation  Professor 
Affiliation  Datta Meghe Institute Of Higher Education And Research 
Address  Department Of radiodiagnosis, Jawaharlal Nehru Medical College, Sawangi, Wardha, Maharashtra - 442001.

Wardha
MAHARASHTRA
442001
India 
Phone  9822471380  
Fax    
Email  shivalikashikar@gmail.com  
 
Details of Contact Person
Public Query  
Name  Dr Shivali Kashikar 
Designation  Professor 
Affiliation  Datta Meghe Institute Of Higher Education And Research 
Address  Department Of radiodiagnosis, Jawaharlal Nehru Medical College, Sawangi, Wardha, Maharashtra - 442001.

Wardha
MAHARASHTRA
442001
India 
Phone  9822471380  
Fax    
Email  shivalikashikar@gmail.com  
 
Source of Monetary or Material Support  
DATTA MEGHE INSTITUTE OF HIGHER EDUCATION AND RESEARCH, DEPARTMENT OF RADIODIAGNOSIS,SAWANGI, WARDHA, MAHARASHTRA, INDIA 442001. 
 
Primary Sponsor  
Name  Datta Meghe Institute Of Higher Education And Research 
Address  Datta Meghe Institute Of Higher Education And Research, Department Of radiodiagnosis, Jawaharlal Nehru Medical College, Sawangi, Wardha, Maharashtra - 442001. 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
Datta Meghe Institute Of Higher Education And Research  Datta Meghe Institute Of Higher Education And Research, Department Of radiodiagnosis, Jawaharlal Nehru Medical College, Sawangi, Wardha, Maharashtra - 442001. 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Paritosh Bhangale  Datta Meghe Institute Of Higher Education And Research  Datta Meghe Institute Of Higher Education And Research, Department Of Radiodiagnosis, Jawaharlal Nehru Medical College, Sawangi, Wardha, Maharashtra - 442001.
Wardha
MAHARASHTRA 		 9967647919

paritosh.bhangale@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
DATTA MEGHE INSTITUTIONAL ETHICAL COMMITEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: D496||Neoplasm of unspecified behavior of brain,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  0.00 Day(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1.All solid lesions in the supratentorium region of brain detected on MR studies will be taken.
2.All age groups irrespective of sex will be included.
 
 
ExclusionCriteria 
Details  1.Patient having history of cardiac pacemakers, metallic implants insertion, and metallic foreign body in situ.
2.Patient having history of claustrophobia.
3.Supratentorial pathology due to infections,trauma or cerebrovascular accidents will be excluded.
4.Pregnant Patients.
5.Uncooperative patients and patients not giving informed consent.
 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
To evaluate the characteristics, distribution, and localization of the extent of supratentorial tumors by MRI.   4 Months 
 
Secondary Outcome  
Outcome  TimePoints 
To study the role of Conventional MRI,DWI,MR spectroscopy in the evaluation of solid supratentorial tumors.  4 Months 
 
Target Sample Size   Total Sample Size="59"
Sample Size from India="59" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Brain tumors can be categorized as supratentorial, midline or infratentorial tumors based on their location. The use of MR imaging has been widely recognized as the most effective screening technique for detecting intracranial tumors. By utilizing pulse sequences, MRI imaging generates higher contrast resolution between adjacent brain parenchyma and structural irregularities. The administration of paramagnetic contrast agents further enhances MRI’s ability to detect focal lesions of the brain, making it a more sensitive diagnostic tool. In this research study, we analyze the magnetic resonance imaging characteristics of diverse solid neoplasms located above the tentorium cerebelli.

 
Close